Maky Zanganeh Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Maky Zanganeh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Maky Zanganeh. Maky Zanganeh is Chief Business Officer in PHARMACYCLICS INC ($PCYC) and Chief of Staff & VP Bus. Dev. in PHARMACYCLICS INC ($PCYC) and Chief Operating Officer in PHARMACYCLICS INC ($PCYC) and Chief Operating Officer in Summit Therapeutics Inc. ($SMMT) and Director in Summit Therapeutics Inc. ($SMMT) and Director in Pulse Biosciences, Inc. ($PLSE).
Latest Insider Trading Transactions of Maky Zanganeh
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, PCYC, PLSE, SMMT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 18.69 | 8,026 | 150,006 | 8,026 | |
| May 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 18.69 | 20,000 | 373,800 | 20,000 | |
| May 14 2021 | SMMT | Summit Therapeutic ... | Zanganeh Maky | Chief Operating Off ... | Buy | P | 5.24 | 389,077 | 2,038,763 | 2,643,319 | 2.3 M to 2.6 M (+17.26 %) |
| Jan 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | X | 7.01 | 307 | 2,152 | 0 | |
| Jan 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | X | 7.01 | 3,000 | 21,030 | 0 | |
| Jan 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | X | 7.01 | 307 | 2,152 | 107,074 | 106.8 K to 107.1 K (+0.29 %) |
| Jan 21 2021 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | X | 7.01 | 3,000 | 21,030 | 355,500 | 352.5 K to 355.5 K (+0.85 %) |
| Nov 13 2020 | SMMT | Summit Therapeutic ... | Zanganeh Maky | Director | Option Exercise | A | 3.71 | 3,323 | 12,328 | 1,324,500 | |
| Nov 13 2020 | SMMT | Summit Therapeutic ... | Zanganeh Maky | Director | Option Exercise | A | 3.71 | 200,000 | 742,000 | 1,321,177 | |
| Jun 25 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 10.70 | 1,193 | 12,767 | 106,767 | 105.6 K to 106.8 K (+1.13 %) |
| Jun 19 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 7.01 | 7,950 | 55,730 | 105,574 | 97.6 K to 105.6 K (+8.14 %) |
| Jun 17 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | P | 7.01 | 307 | 2,152 | 307 | |
| Jun 17 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | P | 7.01 | 3,000 | 21,030 | 3,000 | |
| Jun 17 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | X | 7.01 | 2,050 | 14,371 | 97,624 | 95.6 K to 97.6 K (+2.14 %) |
| Jun 17 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | X | 7.01 | 20,000 | 140,200 | 352,500 | 332.5 K to 352.5 K (+6.02 %) |
| May 19 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 10.66 | 14,071 | 149,997 | 14,071 | |
| May 19 2020 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 10.66 | 20,000 | 213,200 | 20,000 | |
| Jan 09 2019 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 13.22 | 2,364 | 31,252 | 2,364 | |
| May 24 2018 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 15.27 | 15,000 | 229,050 | 15,000 | |
| Dec 15 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.98 | 1,100 | 26,378 | 95,574 | 94.5 K to 95.6 K (+1.16 %) |
| Dec 13 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.98 | 1,000 | 23,979 | 94,474 | 93.5 K to 94.5 K (+1.07 %) |
| Dec 13 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 22.76 | 3,000 | 68,289 | 93,474 | 90.5 K to 93.5 K (+3.32 %) |
| Nov 06 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 23.08 | 20,000 | 461,600 | 20,000 | |
| Sep 18 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 15.02 | 7,775 | 116,791 | 332,500 | 324.7 K to 332.5 K (+2.39 %) |
| Sep 18 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 13.55 | 9,000 | 121,937 | 324,725 | 315.7 K to 324.7 K (+2.85 %) |
| Sep 18 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 12.23 | 13,000 | 158,942 | 315,725 | 302.7 K to 315.7 K (+4.29 %) |
| Aug 04 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.00 | 5,000 | 115,015 | 90,474 | 85.5 K to 90.5 K (+5.85 %) |
| Aug 04 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.89 | 9,500 | 226,955 | 302,725 | 293.2 K to 302.7 K (+3.24 %) |
| Aug 04 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.23 | 6,000 | 139,362 | 293,225 | 287.2 K to 293.2 K (+2.09 %) |
| Aug 04 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 25.15 | 8,290 | 208,469 | 287,225 | 278.9 K to 287.2 K (+2.97 %) |
| May 18 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 27.14 | 15,000 | 407,100 | 15,000 | |
| May 11 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 21.71 | 5,000 | 108,545 | 85,474 | 80.5 K to 85.5 K (+6.21 %) |
| May 11 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 20.16 | 33,760 | 680,500 | 80,474 | 46.7 K to 80.5 K (+72.27 %) |
| May 11 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 20.84 | 15,000 | 312,540 | 278,935 | 263.9 K to 278.9 K (+5.68 %) |
| Mar 20 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 23.78 | 1,040 | 24,731 | 46,714 | 45.7 K to 46.7 K (+2.28 %) |
| Mar 20 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 22.71 | 3,240 | 73,574 | 45,674 | 42.4 K to 45.7 K (+7.64 %) |
| Mar 20 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 24.00 | 8,960 | 215,004 | 42,434 | 33.5 K to 42.4 K (+26.77 %) |
| Mar 20 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 22.47 | 5,000 | 112,360 | 263,935 | 258.9 K to 263.9 K (+1.93 %) |
| Feb 22 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Buy | P | 11.97 | 13,000 | 155,649 | 33,474 | 20.5 K to 33.5 K (+63.50 %) |
| Feb 13 2017 | PLSE | Pulse Biosciences, ... | Zanganeh Maky | Director | Option Exercise | A | 7.55 | 45,000 | 339,750 | 45,000 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 102.00 | 40,000 | 4,080,000 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 61.60 | 100,000 | 6,160,000 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 14.92 | 100,000 | 1,492,000 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 5.81 | 25,000 | 145,250 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 7.48 | 10,000 | 74,800 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 7.69 | 30,000 | 230,700 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 6.75 | 10,000 | 67,500 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 7.19 | 114,069 | 820,156 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | D | 0.75 | 37,500 | 28,125 | 0 | |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | U | 261.25 | 725 | 189,406 | 0 | 725 to 0 (-100.00 %) |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | U | 261.25 | 900 | 235,125 | 0 | 900 to 0 (-100.00 %) |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | U | 261.25 | 75,363 | 19,688,584 | 0 | 75.4 K to 0 (-100.00 %) |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | U | 261.25 | 351,293 | 91,775,296 | 0 | 351.3 K to 0 (-100.00 %) |
| May 28 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | D | 261.25 | 15,000 | 3,918,750 | 351,293 | 366.3 K to 351.3 K (-4.10 %) |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 0.75 | 92,500 | 69,375 | 37,500 | |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 2.30 | 48,219 | 110,904 | 0 | |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 7.19 | 30,000 | 215,700 | 114,069 | |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | M | 2.30 | 48,219 | 110,904 | 366,031 | 414.3 K to 366 K (-11.64 %) |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 0.75 | 92,500 | 69,375 | 317,812 | 225.3 K to 317.8 K (+41.05 %) |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 254.12 | 30,000 | 7,623,444 | 225,312 | 255.3 K to 225.3 K (-11.75 %) |
| Mar 13 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 7.19 | 30,000 | 215,700 | 255,312 | 225.3 K to 255.3 K (+13.31 %) |
| Jan 21 2015 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Grant | A | 0.00 | 15,000 | 0 | 225,312 | 210.3 K to 225.3 K (+7.13 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 7.19 | 5,931 | 42,644 | 144,069 | |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 2.30 | 23,000 | 52,900 | 48,219 | |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 2.30 | 1,551 | 3,567 | 71,219 | |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 137.50 | 658 | 90,475 | 210,312 | 211 K to 210.3 K (-0.31 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 138.01 | 5,273 | 727,741 | 210,970 | 216.2 K to 211 K (-2.44 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 7.19 | 5,931 | 42,644 | 216,243 | 210.3 K to 216.2 K (+2.82 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 133.88 | 6,476 | 866,997 | 210,312 | 216.8 K to 210.3 K (-2.99 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 133.76 | 5,000 | 668,808 | 216,788 | 221.8 K to 216.8 K (-2.25 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 133.94 | 8,524 | 1,141,722 | 221,788 | 230.3 K to 221.8 K (-3.70 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 133.50 | 3,000 | 400,500 | 230,312 | 233.3 K to 230.3 K (-1.29 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 2.30 | 23,000 | 52,900 | 233,312 | 210.3 K to 233.3 K (+10.94 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 135.01 | 1,551 | 209,401 | 210,312 | 211.9 K to 210.3 K (-0.73 %) |
| Nov 12 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 2.30 | 1,551 | 3,567 | 211,863 | 210.3 K to 211.9 K (+0.74 %) |
| Nov 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | J | 80.93 | 1 | 81 | 210,312 | 210.3 K to 210.3 K (0.00 %) |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 2.30 | 5,000 | 11,500 | 72,770 | |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | M | 2.30 | 7,000 | 16,100 | 77,770 | |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 122.00 | 5,000 | 610,000 | 210,311 | 215.3 K to 210.3 K (-2.32 %) |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 2.30 | 5,000 | 11,500 | 215,311 | 210.3 K to 215.3 K (+2.38 %) |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 121.10 | 5,000 | 605,500 | 210,311 | 215.3 K to 210.3 K (-2.32 %) |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 122.74 | 2,000 | 245,480 | 215,311 | 217.3 K to 215.3 K (-0.92 %) |
| Sep 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | M | 2.30 | 7,000 | 16,100 | 217,311 | 210.3 K to 217.3 K (+3.33 %) |
| May 01 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | J | 80.39 | 204 | 16,400 | 210,311 | 210.1 K to 210.3 K (+0.10 %) |
| Apr 04 2014 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | A | 102.22 | 40,000 | 4,088,800 | 40,000 | |
| Dec 18 2013 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Sell | S | 107.55 | 20,000 | 2,151,000 | 210,107 | 230.1 K to 210.1 K (-8.69 %) |
| May 01 2013 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Buy | J | 10.56 | 2,012 | 21,241 | 230,107 | 228.1 K to 230.1 K (+0.88 %) |
| Oct 29 2012 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Operating Off ... | Option Exercise | A | 61.60 | 100,000 | 6,160,000 | 100,000 | |
| May 02 2012 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Business Offi ... | Buy | J | 10.56 | 2,012 | 21,241 | 228,095 | 226.1 K to 228.1 K (+0.89 %) |
| Dec 05 2011 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief Business Offi ... | Option Exercise | M | 14.92 | 100,000 | 1,492,000 | 100,000 | |
| May 02 2011 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief of Staff & VP ... | Option Exercise | M | 0.75 | 20,000 | 15,000 | 130,000 | |
| May 02 2011 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief of Staff & VP ... | Buy | M | 0.75 | 20,000 | 15,000 | 226,083 | 206.1 K to 226.1 K (+9.70 %) |
| Dec 15 2010 | PCYC | PHARMACYCLICS INC | Zanganeh Maky | Chief of Staff & VP ... | Option Exercise | A | 5.81 | 25,000 | 145,250 | 25,000 |
Page: 1